Skip to Main Content

Author Details

Joel S Raichlen
AstraZeneca Pharmaceuticals LP
1976
72
33
PMIDPaper TitleJournal TitlePublished Year
32064957Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies.Expert Opin Drug Saf2020
29431667Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)".Circulation2018
29898827LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial.Int J Cardiol2018
27830951Drug-induced blood pressure increase - recommendations for assessment in clinical and non-clinical studies.Expert Opin Drug Saf2017
28592434Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).Circulation2017
28641153Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.Atherosclerosis2017
28838366Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.J Am Coll Cardiol2017
26687694Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.J Clin Lipidol2015
24448227Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.Eur Heart J Cardiovasc Imaging2014
25190674High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.Diabetes Care2014
25240453Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.JACC Cardiovasc Imaging2014
25212234Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.Arterioscler Thromb Vasc Biol2014
23237107Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).Am J Cardiol2013
24043299C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.Circulation2013
23886915Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.Eur Heart J2013
23644179Factors underlying regression of coronary atheroma with potent statin therapy.Eur Heart J2013
21726301Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.J Intern Med2012
23194484Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.Am Heart J2012
22717926The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).EuroIntervention2012
22884641Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.J Am Soc Echocardiogr2012
22536884Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.Curr Med Res Opin2012
22439736Sample size requirements in trials using repeated measurements and the impact of trial design.Curr Med Res Opin2012
22459429Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.J Clin Epidemiol2012
22561300Subharmonic microbubble emissions for noninvasively tracking right ventricular pressures.Am J Physiol Heart Circ Physiol2012
22239898Noninvasive LV pressure estimation using subharmonic emissions from microbubbles.JACC Cardiovasc Imaging2012
22360820Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).Am J Cardiol2012
22172243Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study.J Intern Med2012
21982737Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.J Am Soc Echocardiogr2012
21613319Asymmetrical distribution of atherosclerosis in the carotid artery: identical patterns across age, race, and gender.Eur J Prev Cardiol2012
21446892Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).Curr Med Res Opin2011
22085316Effect of two intensive statin regimens on progression of coronary disease.N Engl J Med2011
21918474Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.J Hypertens2011
21617330The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.J Atheroscler Thromb2011
21546878Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study.J Hypertens2011
20038840Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.Eur J Cardiovasc Prev Rehabil2010
20412373C-reactive protein lowering with rosuvastatin in the METEOR study.J Intern Med2010
19298496Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.J Intern Med2009
19576317Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).Am J Cardiol2009
18402897Lipid levels after acute coronary syndromes.J Am Coll Cardiol2008
18702965Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.J Am Coll Cardiol2008
18294500Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.Am Heart J2008
18378607Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.Circulation2008
17384434Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.JAMA2007
17355745Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.Curr Med Res Opin2007
16644314Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.Am Heart J2006
16533939Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.JAMA2006
15472094Determination of carotid artery atherosclerotic lesion type and distribution in hypercholesterolemic patients with moderate carotid stenosis using noninvasive magnetic resonance imaging.Stroke2004
15230482Effect of contrast enhancement on measurement of carotid artery intimal medial thickness.Vasc Med2004
15229392Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.Cardiovasc Drugs Ther2004
10320317Pressure dependence of subharmonic signals from contrast microbubbles.Ultrasound Med Biol1999
  • 1 - 50 of 72

Recommended Authors

Hena Patel
University of Chicago Medical Center
Career Start Year 2008
Number of shared co-authors 1
Hind Rahmouni
Knight Cardiovascular Institute, Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 0
John W Petersen
University of Florida College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Vijay Nambi
Baylor College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Eric J Velazquez
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 2
Michael D Shapiro
Wake Forest University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
Andrew D Michaels
NYCHHC/Elmhurst Hospital Center
Career Start Year 1996
Number of shared co-authors 1
Ellen C Keeley
University of Florida
Career Start Year 1995
Number of shared co-authors 0
Rosario Rossi
University of Modena and Reggio Emilia, Policlinico di Modena
Career Start Year 1994
Number of shared co-authors 0
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 1
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 2
Sunil Mankad
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Thomas C Gerber
Mayo Clinic College of Medicine and Science
Career Start Year 1991
Number of shared co-authors 1
Kalon K L Ho
Beth Israel Deaconess Medical Center
Career Start Year 1990
Number of shared co-authors 1
James E Udelson
Tufts Medical Center
Career Start Year 1989
Number of shared co-authors 4
Yochai Birnbaum
Baylor College of Medicine
Career Start Year 1989
Number of shared co-authors 1
Jae K Oh
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 2
Patricia A Pellikka
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 4
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 1
Daniel M Kolansky
University of Pennsylvania Perelman School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Francisco Fern??ndez-Avil??s
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 0
Eric J Topol
Universidade Federal de Sao Paulo
Career Start Year 1975
Number of shared co-authors 5
Georg Ertl
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 1
Dimitrios Th Kremastinos
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 0
Robert O Bonow
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 5
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 3
Ezra A Amsterdam
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 1
Allen J Taylor
Uniformed University of the Health Sciences
Career Start Year 1842
Number of shared co-authors 3

Collaborators

Diederick E Grobbee
Co-authored papers 18
Christie M Ballantyne
Baylor College of Medicine
Co-authored papers 15
Peter Libby
Co-authored papers 12
Raimund Erbel
Co-authored papers 12
Philip J Barter
Co-authored papers 10
John J P Kastelein
Co-authored papers 5
Daniel Gaudet
Co-authored papers 4
Dennis A Tighe
University of Massachusetts Chan Medical School
Co-authored papers 4
Lars Lind
Co-authored papers 3
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Co-authored papers 2
A.R. Maniet
Co-authored papers 2
James J Paul
University of Utah
Co-authored papers 2
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Co-authored papers 2
John D Mannion
Bayhealth Medical Center
Co-authored papers 1
Elyse Foster
University of California San Francisco (S.B., Western University
Co-authored papers 1
Karel G M Moons
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Co-authored papers 1
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Co-authored papers 1
Thomas A Pearson
Departments of Epidemiology and Health Services Research, University of Florida
Co-authored papers 1
Joseph E Flack
Baystate Medical Center
Co-authored papers 1
Robert D Rifkin
Washington University in St. Louis
Co-authored papers 1
Anthony N DeMaria
Co-authored papers 1
JoAnn Lindenfeld
Vanderbilt University Medical Center
Co-authored papers 1
Carolyn S P Lam
Duke-NUS Medical School
Co-authored papers 1
Release 1.2